Komori
Ibiden (4062) · InitiativeAdvanced

R&D for Next-Generation and Subsequent-Generation Products

First written in FY2016. 21 of 32 entries say "Restated". Latest entry: 2026-10-02.

32entries
11years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2018-Q1 – FY2020-Q2AdvancedFY2025 – 2026-10-022016: 320162017: 420172018: 320182019: 420192020: 320202021: 420212022: 220222023: 220232024: 320242025: 220252026: 22026
Same theme, other companies

1 other company's latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. 2026-10-02AdvancedGovernance

    「We will also focus on developing next-generation and subsequent-generation technologies, including embedded components, glass cores and optoelectronic integration, and maintain a firm position in the high-end market by providing value one step ahead of our customers.」

    Embedded components, glass cores and optoelectronic integration were specifically identified as next-generation and subsequent-generation IC package substrate technologies.
  2. FY2026AdvancedAnnual report

    「The Technology Development Division is working to create businesses in new fields in addition to advancing existing core technologies. To create new businesses, it has established a business development structure incorporating multiple functions to quickly identify customers' future needs and social issues. It has also begun preparations to establish a technology development research institute to strengthen collaboration among industry, academia and government toward the creation of new businesses.」

    The company continued its multifunctional development structure focused on commercialization and began preparations to establish a technology development research institute to strengthen industry-academia-government collaboration. R&D expenses were ¥29,916 million, up from ¥27,451 million in the previous fiscal year.
  3. FY2026-H1AdvancedAnnual report

    「The total amount of R&D activities for the group's consolidated interim period was ¥15,958 million.」

    Interim R&D expenses were ¥15,958 million, up from ¥11,960 million in the same period of the previous fiscal year. The company stated that there were no material changes in the status of its R&D activities.
  4. FY2025AdvancedAnnual report

    「The group's total R&D expenses for the consolidated fiscal year were ¥27,451 million.」

    R&D expenses increased from ¥20,229 million in the previous fiscal year to ¥27,451 million. In the electronics business, the company is developing high-performance circuit boards for AI, data centers and other applications, while in the ceramics business it is developing NEV safety components, semiconductor-related components and high-performance exhaust-system components.
  5. FY2025-H1RestatedAnnual report

    「The total amount of R&D activities for the group's consolidated interim period was ¥11,960 million. There were no material changes in the status of the group's R&D activities during the consolidated interim period.」

    The company stated that there were no material changes in its R&D activities and reported interim R&D expenses of ¥11,960 million.
  6. FY2024AdvancedAnnual report

    「The Technology Development Division has established a business development structure incorporating multiple functions to quickly identify customers' future needs and social issues and rapidly link them to commercialization. In addition to advancing existing core technologies, it is also exploring businesses in new fields. The group's total R&D expenses for the consolidated fiscal year were ¥20,229 million.」

    The company continued its multifunctional development structure focused on commercialization and its exploration of new fields, while R&D expenses increased from ¥19,682 million in the previous fiscal year to ¥20,229 million.
  7. FY2024-Q3RestatedAnnual report

    「The total amount of R&D activities for the group's consolidated nine-month period was ¥15,033 million. There were no material changes in the status of the group's R&D activities during the consolidated nine-month period.」

    R&D expenses for the consolidated nine-month period were ¥15,033 million, and the company stated that there were no material changes in the status of its R&D activities.
  8. FY2023AdvancedAnnual report

    「The group's total R&D expenses for the consolidated fiscal year were ¥19,682 million.」

    R&D expenses increased from ¥15,733 million in the previous fiscal year to ¥19,682 million, and the company is advancing the development of product designs, elemental technologies, process technologies, NEV-related components, semiconductor-related components and other products in the electronics, ceramics and new fields.
  9. FY2023-Q3RestatedAnnual report

    「The total amount of R&D activities for the group's consolidated nine-month period was ¥14,999 million. There were no material changes in the status of the group's R&D activities during the consolidated nine-month period.」

    R&D expenses for the consolidated nine-month period were ¥14,999 million, and there were no material changes in R&D activities.
  10. FY2022AdvancedAnnual report

    「Taking into account the relevance of new product development areas to its core businesses, the company has narrowed its target areas to 3, and has been reorganizing its development organization within the Technology Development Headquarters since fiscal 2022.」

    In R&D, the company narrowed its development fields to 3 areas: electronics, NEV, and new fields including GX-related activities, and began reorganizing the Technology Development Division and concentrating R&D resources in fiscal 2022.
  11. FY2022-Q3RestatedAnnual report

    「The amount spent on R&D activities by the group as a whole during the first nine months of the current fiscal year was ¥11,414 million. There were no material changes in the status of the group’s R&D activities during the period.」

    The company stated that there were no material changes in its R&D activities and reported cumulative third-quarter R&D expenses of ¥11,414 million.
  12. FY2022-Q2RestatedAnnual report

    「The amount spent on R&D activities by the group as a whole during the first six months of the current fiscal year was ¥7,484 million. There were no material changes in the status of the group’s R&D activities during the period.」

    The company reported cumulative second-quarter R&D expenses of ¥7,484 million and stated that there were no material changes in its R&D activities.
  13. FY2022-Q1RestatedAnnual report

    「The amount spent on R&D activities by the group as a whole during the first three months of the current fiscal year was ¥3,594 million. There were no material changes in the status of the group’s R&D activities during the period.」

    The company reaffirmed that there were no material changes in its R&D activities and reported cumulative first-quarter R&D expenses of ¥3,594 million.
  14. FY2021AdvancedAnnual report

    「To quickly identify customers’ future needs and social issues, the technology development divisions have incorporated a marketing function into the development department and established an integrated development structure focused on commercialization. They will also actively explore new businesses and strategically advance product development that can become a pillar of new businesses by evolving existing core technologies and using open innovation.」

    After reorganizing from 4 development centers into in-house projects, the company has continued a commercialization-focused development structure incorporating marketing functions, as well as open innovation. R&D expenses totaled ¥16,841 million.
  15. FY2021-Q3RestatedAnnual report

    「The amount spent on R&D activities by the group as a whole during the first nine months of the current fiscal year was ¥12,638 million. There were no material changes in the status of the group’s R&D activities during the period.」

    The company stated that there were no material changes in its R&D activities and reported cumulative third-quarter R&D expenses of ¥12,638 million.
  16. FY2021-Q2RestatedAnnual report

    「The amount spent on R&D activities by the group as a whole during the first six months of the current fiscal year was ¥8,803 million. There were no material changes in the status of the group’s R&D activities during the period.」

    The company reported cumulative second-quarter R&D expenses of ¥8,803 million and stated that there were no material changes in its R&D activities.
  17. FY2021-Q1RestatedAnnual report

    「The amount spent on R&D activities by the group as a whole during the first three months of the current fiscal year was ¥3,948 million. There were no material changes in the status of the group’s R&D activities during the period.」

    The company recorded cumulative first-quarter R&D expenses of ¥3,948 million and stated that there were no material changes in its R&D activities.
  18. FY2020ReframedAnnual report

    「The technology development divisions dissolved the 4 development centers as part of a transition and launched 2 new projects, accelerating activities aimed at commercialization. They will actively explore new businesses and strategically advance product development that can become a pillar of new businesses by evolving existing core technologies and using open innovation.」

    The company reorganized its structure from the previous 4 development centers into 2 in-house projects at the end of fiscal 2019, creating a development structure focused on commercialization.
  19. FY2020-Q2RestatedAnnual report

    「The amount spent on R&D activities by the group as a whole during the first six months of the current fiscal year was ¥7,565 million. There were no material changes in the status of the group’s R&D activities during the period.」

    The company recorded cumulative second-quarter R&D expenses of ¥7,565 million and stated that there were no material changes in its R&D activities.
  20. FY2020-Q1RestatedAnnual report

    「The amount spent on R&D activities by the group as a whole during the first three months of the current fiscal year was ¥3,788 million. There were no material changes in the status of the group’s R&D activities during the period.」

    The company recorded cumulative first-quarter R&D expenses of ¥3,788 million and stated that there were no material changes in its R&D activities.
  21. FY2019RestatedAnnual report

    「Centered on the 4 development centers established to create a future of sustainable growth, the technology development divisions are developing new products for emerging markets and applications by advancing existing core technologies and actively using open innovation.」

    The company continues to develop next-generation products centered on 4 development centers and has outlined an R&D policy that includes the use of open innovation. Group-wide R&D expenses were ¥14,753 million.
  22. FY2019-Q3RestatedAnnual report

    「The amount spent on R&D activities by the group as a whole during the first nine months of the current fiscal year was ¥10,543 million. There were no material changes in the status of the group’s R&D activities during the period.」

    The company reaffirmed that there were no material changes in its R&D activities and reported cumulative third-quarter R&D expenses of ¥10,543 million.
  23. FY2019-Q2RestatedAnnual report

    「The amount spent on R&D activities by the group as a whole during the first six months of the current fiscal year was ¥6,994 million. There were no material changes in the status of the group’s R&D activities during the period.」

    The company reaffirmed that there were no material changes in its R&D activities and reported cumulative second-quarter R&D expenses of ¥6,994 million.
  24. FY2019-Q1RestatedAnnual report

    「The amount spent on R&D activities by the group as a whole during the first three months of the current fiscal year was ¥3,388 million. There were no material changes in the status of the group’s R&D activities during the period.」

    The company reaffirmed that there were no material changes in its R&D activities and reported cumulative first-quarter R&D expenses of ¥3,388 million.
  25. FY2018-Q3RestatedAnnual report

    「The amount spent on R&D activities by the group as a whole during the first nine months of the current fiscal year was ¥11,379 million. There were no material changes in the status of the group’s R&D activities during the period.」

    The company reaffirmed that there were no material changes in its R&D activities and reported cumulative R&D expenses of ¥11,379 million.
  26. FY2018-Q2RestatedAnnual report

    「The amount spent on R&D activities by the group as a whole during the first six months of the current fiscal year was ¥7,800 million. There were no material changes in the status of the group’s R&D activities during the period.」

    The company reaffirmed that there were no material changes in its R&D activities and reported cumulative R&D expenses of ¥7,800 million.
  27. FY2018-Q1RestatedAnnual report

    「The amount spent on R&D activities by the group as a whole during the first three months of the current fiscal year was ¥3,694 million. There were no material changes in the status of the group’s R&D activities during the period.」

    The company confirmed that there were no material changes in its R&D activities and reported quarterly R&D expenses of ¥3,694 million.
  28. FY2017RaisedAnnual report

    「To achieve stable growth over the medium to long term, and to establish new business pillars following its existing electronics, ceramics, and other businesses, the company plans to accelerate new product development and bring products to market earlier. From fiscal 2017, it launched the Automotive Functional Products Development Center, Future Mobility Products Development Center, Advanced Ceramics Development Center, and Biomaterials Development Center, and plans to increase R&D spending.」

    In addition to its existing development of next-generation and subsequent-generation products, the company plans to launch 4 development centers and increase R&D spending, expanding the scope of its activities.
  29. FY2017-Q3RestatedAnnual report

    「The amount spent on R&D activities by the group as a whole during the first nine months of the current fiscal year was ¥10,036 million. There were no material changes in the status of the group’s R&D activities during the period.」

    The company reaffirmed that there were no material changes in its R&D activities and reported cumulative R&D expenses of ¥10,036 million.
  30. FY2017-Q2RestatedAnnual report

    「The amount spent on R&D activities by the group as a whole during the first six months of the current fiscal year was ¥6,908 million. There were no material changes in the status of the group’s R&D activities during the period.」

    The company reaffirmed that there were no material changes in its R&D activities and reported cumulative R&D expenses of ¥6,908 million.
  31. FY2017-Q1RestatedAnnual report

    「The amount spent on R&D activities by the group as a whole during the first three quarters of the current fiscal year was ¥3,495 million. There were no material changes in the status of the group’s R&D activities during the period.」

    The company reaffirmed that there were no material changes in its R&D activities and reported quarterly R&D expenses of ¥3,495 million.
  32. FY2016First statedAnnual report

    「In the technology development divisions, we are deepening our core technologies and planning products based on proprietary marketing in the electronics and ceramics fields, while conducting research and development to create original new products for the next and subsequent generations.」

    The company is advancing core technologies, product planning, and new product development in both the electronics and ceramics fields, and recorded R&D expenses of ¥15,203 million for the fiscal year.
Moved together

"Fair and Swift Management through Outside Directors and an Executive Officer System" moved the same way as this thread, in the same document, in 7 of its 32 moves.

766555★123456
  1. ★This thread
  2. 1Fair and Swift Management through Outside Directors and an Executive Officer System7×
  3. 2Capital Investment to Expand Production Capacity6×
  4. 3Business Structural Reform and Review of the Production Structure in the Electronics Segment6×
  5. 4Supplementing Orders for the Electronics Business by Developing New Customers and New Fields5×
  6. 5Sustainable Growth and Stable Profit Generation under the Medium-Term Management Plan5×
  7. 6Establishing other businesses as the third source of revenue5×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Ibiden's next results are scheduled for 2026-10-29. Read the earnings preview It last moved in the Governance of 2026-10-02: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
R&D for Next-Generation and Subsequent-Generation Products | IBIDEN CO.,LTD. (4062) | Komori